Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Treosulfan Conditioning in NBS HSCT
NCT04400045Phase 2Unknown
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- May 2020
- Primary completion
- May 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of treosulfan in Nijmegen breakage syndrome (NBS), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Status: unknown.
02
Drugs
treosulfan
03
Conditions
Nijmegen breakage syndrome (NBS)
Beyond the preview
Go deeper on NCT04400045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400045.